Status:
COMPLETED
Synbiotics in Infants With Cyanotic Congenital Heart Disease
Lead Sponsor:
Dr. Sami Ulus Children's Hospital
Conditions:
Congenital Heart Disease
Eligibility:
All Genders
1-3 years
Phase:
NA
Brief Summary
Infants with congenital heart disease have more frequent infections and exposures to antibiotics than healthy infants. The investigators hypothesized that synbiotics may reduce the rate of sepsis and ...
Detailed Description
Infants with congenital heart disease have more frequent infections and exposures to antibiotics than healthy infants. Probiotics may prevent pathogen colonization in infants with CHD. Therefore, the ...
Eligibility Criteria
Inclusion
- Cyanotic congenital heart disease
- infants \>35 weeks of gestational age
- Born at or transferred to Sami Ulus CH
Exclusion
- Congenital anomalies of the intestinal tract
Key Trial Info
Start Date :
October 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2013
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01810978
Start Date
October 1 2012
End Date
May 1 2013
Last Update
May 9 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sami Ulus CH
Ankara, Ankara, Turkey (Türkiye), 06120